Two advocates for affordable life-saving drugs share their stories exposing America’s healthcare woes… Read More
The FTC has long protected the power of a few dominant drug middlemen, like CVS, to crush local pharmacies and fleece Medicaid programs. In this ProMarket piece, Stacy Mitchell and Zach Freed look at how the FTC not only failed to act — but worked to stop states from doing so.… Read More
In the Washington Post, Stacy Mitchell explains why we shouldn’t be surprised that West Virginia and North Dakota’s independent pharmacies are beating the chains in vaccine distribution. The small pharmacies have proved remarkably nimble, while CVS and Walgreens have stumbled. … Read More
Host Zach Freed speaks with Jim Hrncir, owner of Las Colinas Pharmacy in Irving, Texas. Zach and Jim discuss how independent pharmacies are responding to the COVID-19 pandemic. … Read More
Many people assume that local pharmacies are declining because they can’t compete. In fact, research by Consumer Reports and others has found that independent pharmacies are highly competitive: compared to chains, they offer better service and cheaper prescriptions, and surveys show many customers prefer them. Why then, are local pharmacies shuttering across the country? One major … Read More
Independent pharmacies could flourish and multiply, helping to solve the growing problem of healthcare deserts — if only policymakers would stand up to the big players in the drug industry.… Read More
In a series of hearings this fall, the Federal Trade Commission will examine whether it should be doing more to check concentrated economic power. ILSR has submitted comments to the agency that highlight the impact of concentration on independent businesses and outline the dangers of Amazon’s platform power. … Read More
A report published by ILSR is recognized as “Best Antitrust and Small Business Article” as part of the annual Jerry S. Cohen Award for Antitrust Scholarship. … Read More
There’s a small group of powerful companies, called pharmacy benefit managers, or PBMs, that increasingly controls the prices of prescription drugs. The results of this market power include higher costs, worse outcomes for patients, and diminishing competition. A new article in the American Prospect looks at the problem and what state and federal governments should do about it, including such solutions as North Dakota’s Pharmacy Ownership Law.… Read More
